The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlue Star Regulatory News (BLU)

Share Price Information for Blue Star (BLU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0325
Bid: 0.03
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.005 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0325
BLU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Option Scheme and Grant of Options

24 Sep 2021 07:00

RNS Number : 8340M
Blue Star Capital plc
24 September 2021
 

24 September 2021

 

Blue Star Capital plc

("Blue Star" or the "Company")

 

Option Scheme and Grant of Options

 

Blue Star Capital plc (AIM: BLU), the investing company with a focus on esports, technology and its applications within media and gaming, announces, further to its announcement of 29 June 2021, that it has adopted a share option scheme (the "Scheme") and granted share options to certain directors.

 

The terms of the Scheme, which is to incentivise management performance for the benefit of all shareholders by way of options which are subject to time and performance conditions, provide that a maximum of 10 per cent. of the Company's issued share capital in aggregate, from time to time, may be issued without the prior approval of shareholders of the Company. The exercise period for options granted under the Scheme is 10 years from the date of grant and the exercise price at grant is ordinarily expected to be at or around the mid-market closing price on or around the day before the grant of any options.

 

Vesting criteria for options granted under the Scheme are as follows:

 

Amount Vesting

Time Condition

Performance Condition

33.3 per cent. ("Tranche One")

On the business day following the date of grant ("Tranche One Vesting Date")

the share price being at least 10 per cent. higher than on the Grant Date

33.3 per cent. ("Tranche two")

On the business day following the first financial year end following the date of grant ("Tranche Two Vesting Date")

the share price being at least 20 per cent. higher than on the Grant Date

33.3 per cent. ("Tranche two")

On the business day following the second financial year end following the date of grant ("Tranche Three Vesting Date")

the share price being at least 30 per cent. higher than on the Grant Date

 

Vesting conditions may be varied or waived provided that any varied vesting condition shall be a fairer measure of performance, as judged at the time, and no more difficult to satisfy than the original vesting condition. The Scheme provides good leaver provisions and other standard terms normally associated with such a scheme.

On 24 September 2021 ("Grant Date"), the Company granted the following options under the Scheme at the mid-market price on the Grant Date:

 

Option holder

 

Number of

Options granted

Exercise Price

Options Granted as Percentage of issued share capital on Grant Date

Sean King

75,000,000

0.14p

1.5%

Brian Rowbotham

75,000,000

0.14p

1.5%

Total

150,000,000

 

3.0%

 

There are no existing options in issue and, as a result of the grant of options above, the Company has outstanding options over 150,000,000 ordinary shares in aggregate representing 3.0 per cent. of the Company's issued share capital on following Admission.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

For further information, please contact:

 

Blue Star Capital plc

+44 (0)20 3608 3019

Derek Lew

 

 

 

Cairn Financial Advisers LLP

+44 (0) 20 7213 0880

(Nominated Adviser)

 

Jo Turner / Liam Murray

 

 

 

Stanford Capital Partners Limited

(Broker)

Patrick Claridge / John Howes / Bob Pountney

+44 (0) 20 3815 8880

 

About Blue Star Capital

 

Blue Star is an investing company with a focus on new technologies. Blue Star's investments include a 27.7% holding in SatoshiPay, a payments business using blockchain technology; investments in 6 early stage esports companies with shareholdings ranging from 6% to 13.6% and a 0.9% investment in Sthaler, an identity and payments technology business which enables a consumer to identify themselves and pay using just their finger.

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

1. Sean King

2. Brian Rowbotham

2

Reason for notification

a.

Position/Status

1. Non-executive Director

2. Non-executive Director

 

b.

Initial notification/

Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Blue Star Capital plc

b.

LEI

 

 

 

213800Y6XGR31P2LKT12

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Options over ordinary shares

 

GB00B02SSZ25

b.

Nature of the transaction

Grant of Options

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

1. 0.14p

2. 0.14p

75,000,000

75,000,000

 

 

d.

Aggregated information

- Aggregated Volume

- Price

 

150,000,000

0.14p

 

e.

Date of the transaction

24/9/2021

f.

Place of the transaction

UK

 

         

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOVARANUKUUR
Date   Source Headline
29th Jun 20157:00 amRNSNew Investment
11th Jun 20153:04 pmRNSUpdate on Investment in DTL Limited - Nektan Plc
27th Mar 20152:22 pmRNSResult of AGM
4th Mar 20157:00 amRNSAnnual Report and Notice of AGM
27th Feb 20157:01 amRNSFinal results for the year ended 30 September 2014
10th Dec 20147:00 amRNSChange of Adviser
1st Dec 20147:00 amRNSUpdate on investment in Vigilant Applications
3rd Nov 20148:01 amRNSUpdate on investment in DTL Limited - Nektan Plc
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:21 pmRNSFurther Subscription
22nd Oct 20148:04 amRNSShare Subscription
3rd Oct 201411:40 amRNSUpdate on investment in DTL Limited - Nektan plc
1st Jul 20147:00 amRNSAppointment of Non-Executive Director
30th Jun 20144:58 pmRNSTotal Voting Rights
27th Jun 20147:00 amRNSInterim Results for the six months ended 31 March
16th Jun 20147:00 amRNSOak Media signs commercial agreement
9th Jun 20147:00 amRNSSubscription, Loan Conversion and Director Dealing
19th May 20147:00 amRNSOak Media signs exclusive agreement with Playboy
24th Apr 20147:00 amRNSOak Media signs licence agreement with RHF
31st Mar 20141:15 pmRNSShareholder Loan Update
31st Mar 20147:00 amRNSInvestee company signs agreement with Nektan
27th Mar 20143:31 pmRNSResult of Annual General Meeting
28th Feb 20147:01 amRNSFinal Results for the year ended 30 September 2013
30th Jan 201411:23 amRNSShareholder Loan Update
31st Dec 20138:00 amRNSTotal Voting Rights
30th Dec 20137:00 amRNSLoan Conversion & Director Share Issue
24th Dec 20137:00 amRNSNew investment, subscription, loan conversion
18th Dec 20131:35 pmRNSResponse to recent share price movement
29th Nov 20134:00 pmRNSTotal Voting Rights
22nd Nov 20131:37 pmRNSPortfolio Update
19th Nov 20137:01 amRNSLoan Conversion
19th Nov 20137:00 amRNSDirectorate Change and Issue of Warrants
30th Oct 201310:17 amRNSResult of GM
7th Oct 20137:00 amRNSProposed subscription and new investing policy
30th Sep 20137:00 amRNSFinancing Update
1st Aug 20137:00 amRNSFinancing Update
28th Jun 20137:01 amRNSInterim Results for six months ended 31 March 2013
28th Jun 20137:00 amRNSFinancing Update and Directorate Change
31st May 20137:00 amRNSDirectorate Change
1st May 20137:00 amRNSHolding(s) in Company
25th Apr 20137:00 amRNSIssue of Equity
17th Apr 20137:00 amRNSShareholder Loan Update
2nd Apr 20137:00 amRNSShareholder Loan Update
27th Mar 20133:57 pmRNSResult of AGM
1st Mar 20137:00 amRNSFinal Results for the year ended 30 September 2012
4th Feb 20138:16 amRNSLoan Update
7th Jan 201310:55 amRNSInvestee company acquired by Digital Barriers
2nd Jan 20138:36 amRNSShareholder Loan Update
3rd Dec 20127:00 amRNSUpdate on Financing Arrangements
16th Oct 20127:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.